Alumina-Supported NiMo Hydrotreating CatalystsAspects of 3D Structure, Synthesis, and Activity by Mengyan Li (1858759)

Alumina-Supported NiMo Hydrotreating CatalystsAspects of 3D Structure, Synthesis, and Activity by Mengyan Li (1858759)

Quercetin Represses Apolipoprotein B Expression by Inhibiting the Transcriptional Activity of C/EBPβ by Makoto Shimizu (29536)

“…Promoter analysis of the human <i>apoB</i> revealed that quercetin response element is localized at the 5′-proximal promoter region, which contains a conserved CCAAT enhancer-binding protein (C/EBP)-response element. …”

Mutations in the Cholesterol Transporter Gene <i>ABCA5</i> Are Associated with Excessive Hair Overgrowth by Gina M. DeStefano (564953)

“…We identified a single base pair substitution in the 5′ donor splice site of intron 32 in the ABC lipid transporter gene <i>ABCA5</i> that leads to aberrant splicing of the transcript and a decrease in protein levels throughout patient hair follicles. …”

Evaluation of High-Dose Vitamin A Treatment in Postmolar Patients with Low and Plateauing Serum Human Chorionic Gonadotropin Levels by Elza Maria Hartmann Uberti (10459809)

“…<div><p>Abstract Objective To compare the effect of high-dose vitamin A (HD Vit-A) use during postmolar follow-up of patients with low and plateauing (L&P) serum human chorionic gonadotropin (hCG) levels, from the moment serum hCG plateaued (P-hCG) to the first normal serum hCG value (< 5IU/L). …”

Both WD and AD shift OD in the binocular V1 in fully adult mice. by Manuel Teichert (6443960)

“…<p>(<b>a, b</b>) V1 activity evoked by visual stimulation of the contra or ipsilateral eye in untreated control mice (n = 5) remained unchanged at 0, 3 and 7 days. …”

Direct counterpart GPC analysis of tightly-bound sugars in OE control and XTH43-RNAi samples and RNAi control and XTH43-RNAi samples. by Prakash M. Niraula (6816713)

GPC and PCA analysis of loosely-bound sugars in OE control compared to XTH43 samples and RNAi control compared to XTH43-RNAi samples. by Prakash M. Niraula (6816713)

Direct GPC and PCA analysis of loosely-bound sugars in OE control compared to RNAi control and XTH43-OE compared to XTH43-RNAi samples. by Prakash M. Niraula (6816713)

Direct GPC and PCA analysis of tightly-bound sugars in OE control compared to RNAi controls and XTH43-OE compared to XTH43-RNAi samples. by Prakash M. Niraula (6816713)

Direct counterpart GPC analysis of loosely-bound sugars in OE control and XTH43-RNAi samples and RNAi control and XTH43-RNAi samples. by Prakash M. Niraula (6816713)

GPC and PCA analysis of tightly-bound sugars in RNAi control compared to XTH43 samples and RNAi control compared to XTH43-RNAi samples. by Prakash M. Niraula (6816713)

Table_5_Mycobiome of Fraxinus excelsior With Different Phenotypic Susceptibility to Ash Dieback.docx by Marta Agostinelli (10268201)

Algorithm approach for revision surgery following late-onset bleb complications after trabeculectomy: long-term follow-up by Claudio I. Perez (5763428)

“…<div><p>ABSTRACT Purpose: The aim of this study was to introduce a reproducible algorithm for the surgical management of late-onset (>2 months) bleb complications after trabeculectomy with mitomycin C. …”

Isodensity pattern of model with chamfer and convex angle (L/D = 1/6). by Xu Jing (429463)

Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

“…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”

Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

“…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”

Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

“…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”

Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

“…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”

Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

“…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”